|

You Can Now Buy Marley One Functional Mushrooms on Amazon

You Can Now Buy Marley One Functional Mushrooms on Amazon
You Can Now Buy Marley One Functional Mushrooms on Amazon

Mushroom fanatics in the United States can now purchase Silo WellnessMarley One functional mushroom products from the e-commerce platform Amazon.

The Marley One mushroom brand—a collaboration between Toronto-based functional mushroom company Silo Wellness and the family of legendary Jamaican reggae musician Bob Marley—launched earlier this year. Created in the spirit of Marley, the brand’s focus is on offering its customers mushroom-based products that can enhance both their body and mind power.

From today, Amazon is distributing Marley One mushroom products, starting with the brand’s functional mushroom tinctures. Silo Wellness intends to add additional functional mushroom products, including gummies, capsules, and cosmetics. These products will only be available to shoppers throughout the United States.

While this means you can’t get psychedelic mushrooms delivered to your doorstep just yet, this move is significant as it demonstrates how the use of plant therapies, specifically mushroom-based products, is becoming more widely accepted and adopted.

“The listing of Marley One mushrooms on e-commerce giant Amazon is crucial in Silo Wellness’ endeavors to pave a route to the mainstream acceptance of psychedelics and overall de-stigmatization of mushrooms, by way of the functional category,” Silo Wellness CEO Douglas K. Gordon tells Psychedelic Spotlight.

The global functional mushroom market has already exceeded $25 million, with this sector expected to grow at a rate of 8.44% between 2021 and 2026. According to Mordor Intelligence, there is a high demand for safe and natural immune-supportive health products, including supplements that support immune health such as chaga, reishi, cordyceps, and turkey tail—all of which are featured in the Marley One mushroom products. It is also expected over the coming years that functional mushrooms will be incorporated into a range of healthcare and pharmaceutical products, in addition to their increased use in the food and beverage sector.

The launch of Marley One products on Amazon comes after Silo Wellness has lined up more than $4 million in international revenue-driving distribution deals for the brand, which the company says has cemented vital routes to market for the brand in both the United States and the United Kingdom. The company is also pursuing a patent-pending psilocybin nasal spray, runs ketamine-assisted retreats in the state of Oregon, and recently expanded its psychedelic clinics in Jamaica to now offer 5-MeO-DMT-enhanced experiences.

Gordon adds: “As consumer awareness and demand for these powerful fungi grows exponentially, we are laser-focused on generating psychedelic revenue now, both through our psychedelic-assisted retreats in Jamaica and Oregon and sales of our Marley One line of functional mushroom products, which are now easier to access than ever.”

To celebrate the Marley One brand listing on Amazon and National Mushroom Day on October 15, Silo Wellness is offering shoppers 20% off Marley One products on Amazon and the Marley One website. The code “SHROOMDAY20” will be valid until October 15.

Similar Posts

  • Will MAPS IPO? The FIRST American Psychedelic ETF (PSY), New LSD Studies & More

    There were LOTS of general news important for the psychedelic industry as a whole and very important study results that will influence some of our favorite stocks such as MindMed (MMED / MNMD / MMQ) and Compass Pathways (CMPS)!

    In today’s episode we’ll cover a new American psychedelic ETF which is hitting the market under ticker symbol PSY, some new psilocybin and LSD studies, whether MAPS will turn into a public company and some updates on the California and New York bills we have been covering for a while now.

    Enjoy the episode!

    Timestamps:
    0:00 – Intro
    0:40 – The First American Psychedelic ETF (PSY)
    5:50 – MAPS Considering An IPO?
    12:28 – Psilocybin Assisted-Therapy Is 4-Times More Effective Than Typical SSRIs
    15:29 – New Study On How LSD Affects The Brain
    21:08 – The California Senate Has Approved a Bill To Legalize the Possession Of Psychedelics Like Psilocybin And LSD
    23:00 – New York Bill Proposes State-Sponsored Psychedelic Research Institute

    Links:
    New Psychedelic ETF (NYSE : PSY) :
    https://www.defianceetfs.com/psy/
    https://psychedelicspotlight.com/psy-first-u-s-psychedelic-etf/

    Maps Considering An IPO?:
    https://www.reddit.com/r/shroomstocks/comments/nqoy0z/maps_considering_ipo/
    https://youtu.be/v2HycPpjf6Y

    Study Shows Psilocybin Assisted-Therapy Is 4-Times More Effective Than Typical Antidepressants:
    https://thedalesreport.com/psychedelics/study-shows-psilocybin-assisted-therapy-4-times-more-effective-than-typical-antidepressants/

    New Study On How LSD Affects The Brain:
    https://www.theguardian.com/science/2021/may/19/acid-test-scientists-show-how-lsd-opens-doors-of-perception

    The California Senate Has Approved a Bill To Legalize the Possession Of Psychedelics Like Psilocybin And LSD:
    https://www.marijuanamoment.net/california-senate-approves-bill-to-legalize-possession-of-psychedelics-like-psilocybin-and-lsd/

    New York Bill Proposes State-Sponsored Psychedelic Research Institute:
    https://psychedelicspotlight.com/new-york-bill-psychedelic-research-institute/

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌

    Instagram: @thepsychedelicinvestor
    Email: thepsychedelicinvestor@gmail.com
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com
    Video editing: @themyaholy
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    #MindMed #PsychedelicStocks #MAPS

  • Why the SHROOM BOOM Isn’t Just About Psychedelic Mushrooms

    How mushrooms are taking over the healthcare industry, and how investors can profit off of this. First we will talk about how they are being used as treatments for mental health conditions. And then we will talk about how regular, non psychedelic mushrooms are being used to promote healthy lifestyles, and perhaps even lengthen lifespans and increase quality of life.
    The psychedelic craze has overshadowed another important facet of mushrooms and the Shroom Boom.
    The health benefits and investing opportunities of non-psychedelic mushrooms.
    Fungi like Lion’s Mane, Chaga and reishi have a variety of health benefits, and have recently been labelled as superfoods.
    For example, Reishi mushrooms, which have been “revered in Asian societies for thousands of years”, have antibacterial, antiviral, and anti-fungal characteristics, and is high in proteins and vitamins.
    While this is great news for you health, and I personally incorporate mushroom extracts into my diet, on this channel we also focuses on investing.
    According to the Grand View Research Corporation, the global mushroom market, not including the psychedelic variety, is set to grow to an eye watering $50 billion annually by 2025.

    Remember to Like, Subscribe, and SMASH that notifications bell to keep up to date on all the latest Psychedelic Stocks news!
    Follow us on social media! 🙌
    Instagram: @psychedelicinvestor
    Email: thepsychedelicinvestor@gmail.com
    Facebook: @thepsychedelicinvestor
    Music: www.bensound.com
    https://benzinga.grsm.io/jameshallifax1834
    https://benzinga.grsm.io/thepsychedelicinvestor

    DISCLAIMER: I am not a financial adviser nor a CPA. These videos are for educational and entertainment purposes only. Investing of any kind involves risk. While it is possible to minimize risk, your investments are solely your responsibility. It is imperative that you conduct your own research. I am merely sharing my opinion with no guarantee of gains or losses on investments.

    All of the information in this video is public information that James (The Psychedelic Investor) believes to be reliable but it is not guaranteed to be 100% accurate and as such should not be used as advice. Any opinions or thoughts from James (The Psychedelic Investor) are subject to change.

    The Psychedelic Investor was compensated $1,000 by Future Money Trends for the having the interview with PlantX CEO. James (The Psychedelic Investor) does not own a position in PlantX and will not open one for at least 30 days after publication of this video.

    Full Disclaimer
    https://www.goldstandardir.com/plantx-life-disclaimer-85/

    #ShroomBoom​​​ ​#PlantX​​​ #PsychedelicStocks